TrialClinical drug investigation2009

Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.

Majid Vakily et al.PubMed ↗Publisher ↗

No numbers read from the abstract.